Bharat Biotech's COVID-19 intranasal vaccine gets 'emergency use' approval in India

Vaccines |  News | 0 Comment | 07 Sep, 2022

Indian firm Bharat Biotech has announced that iNCOVACC (BBV154) has received approval under Restricted Use in Emergency ...Read more

China's Sinovac makes progress with trivalent COVID-19 vaccine

Vaccines |  News | 0 Comment | 07 Sep, 2022

China-based Sinovac Biotech has announced that the Chilean Public Health Institute (Instituto de Salud Pública, I...Read more

Indonesia approves Takeda's dengue vaccine

Vaccines |  News | 0 Comment | 23 Aug, 2022

Japanese firm Takeda has announced that the company’s dengue vaccine, QDENGA (Dengue Tetravalent Vaccine [Live, At...Read more

Moderna to build first mRNA production facility in Southern Hemisphere

Vaccines |  News | 0 Comment | 16 Aug, 2022

Australia's Monash University has announced that US-based firm Moderna will be joining other world-leading research and ...Read more

CSIRO opens 'missing link' lab to developing Australian vaccine pipeline

Vaccines |  News | 0 Comment | 11 Aug, 2022

Commonwealth Scientific and Industrial Research Organisation (CSIRO), an Australian Government agency responsible for sc...Read more

UK advances key tools for Monkeypox vaccine research

Vaccines |  News | 0 Comment | 01 Aug, 2022

The Coalition for Epidemic Preparedness Innovations (CEPI), Norway has announced funding of up to $375,000 to the UK Med...Read more

Keeping Pace with Mutating Viruses

Vaccines |  Opinion | By Hithaishi C Bhaskar | 0 Comment | 30 Jul, 2022

As of July 2022, uncertainty persists as waves of SARS-CoV-2 continue to emerge. Over time, new virus variants arise and...Read more

World-class Foot and Mouth Disease vaccine site to come up in South Korea

Vaccines |  News | 0 Comment | 26 Jul, 2022

Argentina-based Biogénesis Bagó, an international biotechnology company focused on animal health and globa...Read more

Korea's IVI inks MoU with Moderna for vaccine R&D

Vaccines |  News | 0 Comment | 21 Jul, 2022

South Korea-based International Vaccine Institute (IVI) and US-based Moderna have signed a Memorandum of Understanding (...Read more

SK bioscience to manufacture Novavax' COVID-19 vaccine against omicron

Vaccines |  News | 0 Comment | 22 Jul, 2022

South Korea's SK bioscience has extended its partnership with Novavax, a US-based biotechnology company specializing in ...Read more

Indian Immunologicals opens new facility in New Zealand for sterile filtered serum

Vaccines |  News | 0 Comment | 12 Jul, 2022

Pristine Biologicals NZ, a subsidiary of Indian Immunologicals Ltd (IIL) has inaugurated a new facility in Dargaville fo...Read more

Korea accelerates vaccine sovereignty by developing domestic COVID-19 vaccines

Vaccines |  News | 0 Comment | 01 Jul, 2022

SK bioscience has announced that ‘SKYCovione,’ South Korea’s first COVID-19 vaccine candidate adjuvant...Read more

China's COVID-19 Homologous Booster demonstrates cross-neutralization against Omicron

Vaccines |  News | 0 Comment | 29 Jun, 2022

China's Clover Biopharmaceuticals, a global clinical-stage biotechnology company developing novel vaccines and biol...Read more

Australia's EnGeneIC brings 2nd-Gen COVID-19 vaccine against all variants

Vaccines |  News | 0 Comment | 29 Jun, 2022

Australian biopharma company EnGeneIC is developing the world’s first COVID-19 vaccine which can offer immunity ag...Read more

Facilitating pandemic preparedness in the Asia Pacific through technology transfer initiatives

Vaccines |  Influencers | 4 Comment | 27 Jun, 2022

Asia Pacific is home to more than half of the world’s population and bears a significant burden of infectious dise...Read more

Australia calls for urgent review on vaccines during pregnancy

Vaccines |  News | 0 Comment | 20 Jun, 2022

Australia's University of Queensland (UQ) researchers are calling for an urgent review of low influenza vaccination rate...Read more

Takeda's dengue vaccine proves protection through 4.5 yrs of clinical trials

Vaccines |  News | 0 Comment | 15 Jun, 2022

Japanese pharmaceutical firm Takeda has announced that its dengue vaccine candidate, TAK-003, prevented 8...Read more

Korea expands typhoid conjugate vaccine delivery options in public health programmes

Vaccines |  News | 0 Comment | 15 Jun, 2022

A new study jointly conducted by South Korea-based International Vaccine Institute (IVI) and collaborators shows multido...Read more